Team Up to Manage IBS: Gastro Endo News Report

(MedPage Today) -- Also, deciding who gets liver transplant takes emotional toll
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news

Related Links:

Conclusions: K19-proficient HCC exhibited poor prognosis owing to extrahepatic recurrence, with molecular signatures differing from those in conventional cancer stem cells, providing novel insights of the heterogeneity underlying tumor development.Liver Cancer
Source: Liver Cancer - Category: Cancer & Oncology Source Type: research
Publication date: Available online 20 August 2018Source: Indian Heart JournalAuthor(s): Shayan Marsia, Ariba Khan, Maryam Khan, Saba Ahmed, Javeria Hayat, Abdul Mannan Khan Minhas, Samir Mirza, Nisar Asmi, Jonathon ConstantinAbstractDonors after brain dead (DBD) have been the major source of organ donation due to good perfusion of the organs. However, due to the mismatch in demand and supply of the organ donors and recipients, organ donation after circulatory death has increased recently all over the world. Kidneys, liver and lungs are being used for transplantation from Donors after circulatory death (DCDDs). Recently, he...
Source: Indian Heart Journal - Category: Cardiology Source Type: research
Liver International,Volume 0, Issue ja, -Not available-.
Source: Liver International - Category: Gastroenterology Authors: Source Type: research
Liver International,Volume 0, Issue ja, -Not available-.
Source: Liver International - Category: Gastroenterology Authors: Source Type: research
ConclusionM2BPGi is a novel marker for liver fibrosis in patients with BA. It is especially useful for following patients with BA with a native liver and supporting liver biopsy interpretation findings.
Source: Pediatric Surgery International - Category: Surgery Source Type: research
Liver Transplantation,Volume 0, Issue ja, -Not available-.
Source: Liver Transplantation - Category: Transplant Surgery Authors: Source Type: research
Natural history of decompensated cirrhosis is characterized by the development of recurrent complications of the disease, leading to frequent hospital admissions, impaired quality of life and increased mortality [1 –5]. Liver transplantation (LT) is the definitive treatment for patients with end-stage liver disease. Patients with decompensated cirrhosis present good outcomes after LT with 3-year survival above 80% [5–8]. However, one of the major concerns is the development of complications while on the wa iting list, which may be a cause of death or may delay or preclude patients with decompensated cirrhosis f...
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
ConclusionsPlasma biomarkers in neurologically deceased donors were associated with organ use. SLPI enhanced prediction within a liver transplantation model, whereas IL-6 before transplantation was significantly associated with recipient 3-year survival.Clinicaltrials.gov: NCT00987714.
Source: Journal of Critical Care - Category: Gastroenterology Source Type: research
Liver Transplantation,Volume 0, Issue ja, -Not available-.
Source: Liver Transplantation - Category: Transplant Surgery Authors: Source Type: research
ConclusionsNAFLD could be dealt with laparoscopic sleeve gastrectomy, preventing its progression into cirrhosis. SG can be performed in patients with obesity and metabolic syndrome, with NAFLD showing satisfactory results 12  months after surgery. NAFLD should be a formal indication for bariatric surgery.
Source: Obesity Surgery - Category: Surgery Source Type: research
More News: Gastroenterology | Liver | Liver Transplant | Primary Care | Transplant Surgery | Transplants | Urology & Nephrology